Labcorp Holdings LH
NYSE LH
$336.49 +0.77 (+0.23%)
As of: Aug 27, 2026 · 3:59 PM EDT

Labcorp Holdings (LH) Liabilities from Discontinued Operations (2017 - 2022)

Labcorp Holdings (LH) posted Liabilities from Discontinued Operations of 657600000.0 for Q4 2022, up 3155.45% sequentially from 20200000.0 in Q4 2017.

Labcorp Holdings (LH) Liabilities from Discontinued Operations (2017 - 2022) Analysis & Trends

Labcorp Holdings has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at 657600000.0 in Q4 2022.

  • Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 657600000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 657600000.0 (changed N/A YoY) and the FY2022 annual result came in at 657600000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations advanced to 657600000.0 in Q4 2022 per LH's latest filing, from 20200000.0 in the prior quarter.
  • Over five years, Liabilities from Discontinued Operations peaked at 657600000.0 in Q4 2022 and troughed at 657600000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Quest Diagnostics 27.10 Bn 26.47 Bn 1.03 Bn

Historic Data

Download Data
DateValue
Dec 31, 2022 898.90 Mn
Dec 31, 2022 898.90 Mn
Jun 30, 2018 82.40 Mn
Jun 30, 2018 82.40 Mn
Dec 31, 2017 66.30 Mn
Dec 31, 2017 66.30 Mn